K. Thirunavukkarasu

Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence

Thirunavukkarasu, A. Cooper, P. Foley, 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

Stanley B. Cohen, X. Mariette, E. Lee, 2017, Annals of the rheumatic diseases.

Disseminated nocardiosis in a bone marrow transplant recipient with chronic GVHD

K. Thirunavukkarasu, K. Bradstock, A. Bhave, 1999, Bone Marrow Transplantation.

Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice

A. Cooper, G. Varigos, K. Thirunavukkarasu, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib

P. Nash, S. Hall, K. Thirunavukkarasu, 2019, RMD Open.

Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population

P. Nash, S. Hall, K. Thirunavukkarasu, 2018, Rheumatology and Therapy.

Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs

K. Thirunavukkarasu, W. Bensen, J. Kaine, 2018, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.